M. Tadayyon

发表

Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice

J. Clapham, M. Cawthorne, J. Arch, 2002, Regulatory Peptides.

Expression of melanin-concentrating hormone receptors in insulin-producing cells: MCH stimulates insulin release in RINm5F and CRI-G1 cell-lines.

G. Hervieu, A. Haynes, M. Tadayyon, 2000, Biochemical and biophysical research communications.

The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids*

J. Chambers, P. Murdock, P. Szekeres, 2003, The Journal of Biological Chemistry.

Chronic Treatment with the Dipeptidyl Peptidase-4 Inhibitor BI 1356 [(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione] Increases Basal Glucagon-Like Peptide-1 and Improves Glycemic Control in Diabetic Rodent Models

M. Tadayyon, M. Mark, L. Thomas, 2009, Journal of Pharmacology and Experimental Therapeutics.

Expression and functional activity of PPAR c in pancreatic b cells 1

N. Morgan, Stephen A. Smith, S. McBain, 2004 .

Modulation by Blood Glucose and Feeding

Shelagh Wilson, J. Clapham, R. Buckingham, 1999 .

The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats.

J. Clapham, M. Cawthorne, S. Dunmore, 1996, Biochemical and biophysical research communications.

Opiate-prostaglandin interactions in the regulation of insulin secretion from rat islets of Langerhans in vitro.

M. Tadayyon, I. Green, 1988, Life sciences.

Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic β-cells exposed to palmitate

N. Morgan, Stephen A. Smith, M. Tadayyon, 2006, Apoptosis.

Evidence that protein kinase Cdelta is not required for palmitate-induced cytotoxicity in BRIN-BD11 beta-cells.

N. Morgan, M. Tadayyon, S. Smith, 2004, Journal of molecular endocrinology.

Key Data from the 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 6–8 November 2008, London, UK

M. Tadayyon, S. Cameron, 2008, Antiviral therapy.

Evidence that protein kinase C (cid:1) is not required for palmitate-induced cytotoxicity in BRIN-BD11 (cid:2) -cells

N. Morgan, M. Tadayyon, S. Smith, 2004 .

Effect of a hypoglycaemic agent M&B 39890A on glucagon secretion in isolated rat islets of Langerhans

D. Cook, M. Tadayyon, J. Pratt, 2005, Diabetologia.

8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes.

H. Nar, P. Sieger, M. Tadayyon, 2007, Journal of medicinal chemistry.

3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: a class of potent DPP-4 inhibitors.

H. Nar, M. Tadayyon, F. Himmelsbach, 2008, Bioorganic & medicinal chemistry letters.

Inhibition of fatty acid synthase prevents preadipocyte differentiation.

B. Hamilton, M. Tadayyon, J. Rippmann, 2005, Biochemical and biophysical research communications.

Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District, United Arab Emirates.

T. Vulliamy, L. Luzzatto, R. Bayoumi, 1996, Human heredity.

Minireview: Challenges and opportunities in development of PPAR agonists.

Martin Bopst, M. Wright, M. Tadayyon, 2014, Molecular endocrinology.

Insulin sensitisation in the treatment of Type 2 diabetes

M. Tadayyon, Sa Smith, 2003, Expert opinion on investigational drugs.

Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat

Shelagh Wilson, J. Arch, R. Buckingham, 1999, Peptides.

Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW1229U91, on the consumption of highly palatable energy-rich diet

J. R. Arch, R. Buckingham, L. Henderson, 1999, Peptides.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models

M. Tadayyon, B. Caplin, O. Sadeghi-Alavijeh, 2017, Cardiovascular endocrinology.

Personalized nutrition in ageing society: redox control of major-age related diseases through the NutRedOx Network (COST Action CA16112)

A. Bartoszek, J. Tur, M. Diederich, 2019, Free radical research.

(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors

M. Tadayyon, F. Himmelsbach, M. Mark, 2008, Journal of Pharmacology and Experimental Therapeutics.

Mono‐unsaturated fatty acids protect against β‐cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure

N. Morgan, Stephen A. Smith, M. Tadayyon, 2004, FEBS letters.

Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.

K. Docherty, E. M. Sinclair, E. Durward, 2005, The Journal of endocrinology.

Reproducibility of targeted gene expression measurements in human islets of Langerhans.

R. Barry, M. Tadayyon, I. Green, 2002, Biochemical and biophysical research communications.

Insulin stimulates pancreatic-duodenal homoeobox factor-1 (PDX1) DNA-binding activity and insulin promoter activity in pancreatic beta cells.

K. Docherty, J. Arch, H. Wu, 1999, The Biochemical journal.

ob gene expression and secretion of leptin following differentiation of rat preadipocytes to adipocytes in primary culture.

W. Rees, J. Arch, N. Hoggard, 1997, Biochemical and biophysical research communications.

Anti-obesity drugs: a critical review of current therapies and future opportunities.

J. Clapham, J. R. Arch, J. Arch, 2001, Pharmacology & therapeutics.

Hypothalamic orexin expression: modulation by blood glucose and feeding.

X. Cai, Shelagh Wilson, G. Williams, 1999, Diabetes.

Expression and functional activity of PPARγ in pancreatic β cells

N. Morgan, Stephen A. Smith, S. McBain, 2004, British journal of pharmacology.

Starvation decreases insulin secretion, prostaglandin E2 production and phospholipase A2 activity in rat pancreatic islets.

M. Tadayyon, I. Green, R. C. Bonney, 1990, The Journal of endocrinology.